414 related articles for article (PubMed ID: 17250819)
21. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
22. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications.
Debruyne EN; Delanghe JR
Clin Chim Acta; 2008 Sep; 395(1-2):19-26. PubMed ID: 18538135
[TBL] [Abstract][Full Text] [Related]
23. Cytoplasmic alpha-fetoprotein functions as a co-repressor in RA-RAR signaling to promote the growth of human hepatoma Bel 7402 cells.
Li M; Li H; Li C; Guo L; Liu H; Zhou S; Liu X; Chen Z; Shi S; Wei J; McNutt MA; Li G
Cancer Lett; 2009 Nov; 285(2):190-9. PubMed ID: 19501957
[TBL] [Abstract][Full Text] [Related]
24. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L
Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505
[TBL] [Abstract][Full Text] [Related]
25. Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence.
Sakisaka S; Watanabe M; Tateishi H; Harada M; Shakado S; Mimura Y; Gondo K; Yoshitake M; Noguchi K; Hino T
Hepatology; 1993 Dec; 18(6):1357-62. PubMed ID: 7694895
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
27. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC).
Chen GG; Ho RL; Wong J; Lee KF; Lai PB
Eur J Surg Oncol; 2007 Sep; 33(7):882-6. PubMed ID: 17433605
[TBL] [Abstract][Full Text] [Related]
28. Concurrent evaluation of p53, beta-catenin, and alpha-fetoprotein expression in human hepatocellular carcinoma.
Torbenson M; Kannangai R; Abraham S; Sahin F; Choti M; Wang J
Am J Clin Pathol; 2004 Sep; 122(3):377-82. PubMed ID: 15362367
[TBL] [Abstract][Full Text] [Related]
29. In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector.
Kim KI; Park JH; Lee YJ; Lee TS; Park JJ; Song I; Nahm SS; Cheon GJ; Lim SM; Chung JK; Kang JH
J Gene Med; 2012 Aug; 14(8):513-20. PubMed ID: 22761128
[TBL] [Abstract][Full Text] [Related]
30. Immunolocalisation of heat shock protein 72 and glycoprotein 96 in colonic adenocarcinoma.
Wang X; Wang Q; Guo L; Ying X; Zhao Y
Acta Histochem; 2008; 110(2):117-23. PubMed ID: 18155754
[TBL] [Abstract][Full Text] [Related]
31. Distribution of alpha-fetoprotein- and albumin-containing cells in the livers of Fischer rats fed four cycles of N-2-fluorenylacetamide.
Sell S
Cancer Res; 1978 Sep; 38(9):3107-13. PubMed ID: 79445
[TBL] [Abstract][Full Text] [Related]
32. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
33. Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell.
Yang X; Zhang Y; Zhang L; Zhang L; Mao J
Cancer Lett; 2008 Nov; 271(2):281-93. PubMed ID: 18657899
[TBL] [Abstract][Full Text] [Related]
34. Fascin expression in progression and prognosis of hepatocellular carcinoma.
Iguchi T; Aishima S; Umeda K; Sanefuji K; Fujita N; Sugimachi K; Gion T; Taketomi A; Maehara Y; Tsuneyoshi M
J Surg Oncol; 2009 Dec; 100(7):575-9. PubMed ID: 19697358
[TBL] [Abstract][Full Text] [Related]
35. Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients.
Bei R; Budillon A; Reale MG; Capuano G; Pomponi D; Budillon G; Frati L; Muraro R
Cancer Res; 1999 Nov; 59(21):5471-4. PubMed ID: 10554020
[TBL] [Abstract][Full Text] [Related]
36. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
Yoon SK; Lim NK; Ha SA; Park YG; Choi JY; Chung KW; Sun HS; Choi MJ; Chung J; Wands JR; Kim JW
Cancer Res; 2004 Aug; 64(15):5434-41. PubMed ID: 15289352
[TBL] [Abstract][Full Text] [Related]
37. Hsp72 controls bortezomib-induced HepG2 cell death via interaction with pro-apoptotic factors.
Calvaruso G; Giuliano M; Portanova P; Pellerito O; Vento R; Tesoriere G
Oncol Rep; 2007 Aug; 18(2):447-50. PubMed ID: 17611669
[TBL] [Abstract][Full Text] [Related]
38. Distribution of albumin- and/or alpha-fetoprotein-positive cells in hepatocellular carcinoma.
Kojiro M; Kawano Y; Isomura T; Nakashima T
Lab Invest; 1981 Mar; 44(3):221-6. PubMed ID: 6162058
[TBL] [Abstract][Full Text] [Related]
39. HSP72 and gp96 in gastroenterological cancers.
Wang X; Wang Q; Lin H; Li S; Sun L; Yang Y
Clin Chim Acta; 2013 Feb; 417():73-9. PubMed ID: 23266770
[TBL] [Abstract][Full Text] [Related]
40. Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma.
Bachtiar I; Santoso JM; Atmanegara B; Gani RA; Hasan I; Lesmana LA; Sulaiman A; Gu J; Tai S
Clin Chim Acta; 2009 Jan; 399(1-2):97-101. PubMed ID: 18926809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]